Book a demo

Chemical intelligence powered by cypris.ai

Propiomazine Hydrochloride

1-[10-[2-(dimethylamino)propyl]phenothiazin-2-yl]propan-1-one;hydrochloride · also: Largon, SureCN720224, Propiomazine HCl, Propiomazinhydrochlorid, 1-(10-(2-(Dimethylamino)propyl)phenothiazin-2-yl)-1-propanone monohydrochloride, 1-Propanone, 1-(10-(2-(dimethylamino)propyl)-10H-phenothiazin-2-yl)-, monohydrochloride

FormulaC20H25ClN2OS
Mol. weight376.943
PubChem CID71802
InChIKeyUGVNGSMLNPWNNA-UHFFFAOYSA-N
SMILESCCC(=O)C1=CC2=C(C=C1)SC3=CC=CC=C3N2CC(C)N(C)C.Cl
87Patents
33Research papers
0Patents - last 3 years
1Papers - last 3 years

Who owns the IP

The organizations most actively patenting around this compound, ranked by referenced patent volume.

#AssigneePatents
1Zalicus Inc30
2Fred Hutchinson Cancer Center19
3Follica Inc8
4Penwest Pharmaceuticals Co7
5Angiotech International AG5
6Puretech Ventures LLC4
7University of Pennsylvania3
8Organon Pharma UK Ltd2
9Agilent Technologies Inc1
10Bayer Oy1

Explore the full landscape

This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.

Visit Cypris

Where innovation is concentrated

Patent classifications ranked by volume reveal the technical domains with the most active filing.

#CodeAreaPatents
1A61KMedicinal preparations61
2A61PTherapeutic activity (drug indications)46
3A01NPreservation of bodies; biocides; pest repellents17
4C12NMicroorganisms, enzymes14
5A61MDevices for introducing media into the body11
6Y02AClimate change adaptation7
7A61B6
8A61QCosmetics, personal care6
9A61F5
10A61LSterilising / disinfecting materials5

AI mapped opportunity space

This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.

See Cypris in action

Who's driving the science

The most-published authors working with this compound, alongside their primary affiliations.

#AuthorAffiliationPapers
1A PosnerHarlem Hospital Center1
2A S RIVERO1
3ANDRES I. REYESMaimonides Medical Center1
4Abdelwahab AhmedMcGill University1
5Adam J. KrakowskiChamplain Valley Physicians Hospital1
6Albert ElmsjöSwedish National Board of Forensic Medicine1
7Anna AxmonLund University1
8Anna NordströmUmeå University1
9Birgitta JonassonUppsala University1
10Bradley E. SmithSt Albans City Hospital1

Research leaders

This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.

See Cypris in action

The literature that defines it

The most-cited papers anchoring the scientific record for this compound.

Frequently asked questions

Common questions about this compound's patent and research landscape, answered from the underlying data.

What is the molecular formula and weight of Propiomazine Hydrochloride?

Propiomazine Hydrochloride has the molecular formula C20H25ClN2OS and a molecular weight of 376.943 g/mol.

Which organization holds the most patents related to Propiomazine Hydrochloride?

Zalicus Inc holds the most patents related to Propiomazine Hydrochloride, with 30 patents in the associated portfolio.

What are the primary research topics associated with published papers on Propiomazine Hydrochloride?

The published papers on Propiomazine Hydrochloride cover several research areas, including Anesthesia and Pain Management, Schizophrenia research and treatment, Heart Failure Treatment and Management, and Microfluidic and Capillary Electrophoresis Applications.

What historical clinical application of Propiomazine Hydrochloride is documented in the research literature?

Propiomazine Hydrochloride was investigated for obstetrical analgesia and maternal-fetal effects when used with meperidine, as documented in papers from 1962.

Which patent classification codes are most frequently associated with Propiomazine Hydrochloride patents?

The most frequently associated CPC subclasses are A61K (61 patents), A61P (46 patents), and A01N (17 patents), reflecting pharmaceutical preparation, therapeutic applications, and biocide classifications.

Turn any compound into a complete chemical intelligence landscape

Go beyond static compound data. Cypris resolves identities, patents, papers, and commercial signals into one AI-powered view - so your team can move from a single chemical question to a complete R&D, IP, and market landscape.

Schedule a free trial